Schneeweiss S, Rassen JA, Glynn RJ, Myers J, Daniel GW, Singer J, Solomon DH, Kim SY, Rothman KJ, Avorn J. Supplementing claims data with outpatient laboratory test results to improve confounding adjustment in effectiveness studies of lipid-lowering treatments. BMC Med Res Methodol. 2012 Nov 26;12(11):180.
Adams MR, Golden DL, Anthony MS, Williams JK. Inhibitory effects of soy protein isolate on atherosclerosis in mice do not require the presence of LDL receptors or effects on plasma lipoproteins. J Nutr. 2002;132:602S.
Anthony MS. Soy and cardiovascular disease: cholesterol lowering and beyond. J Nutr. 2000 Mar;130(3):662S-3S.
Anthony MS, Clarkson TB, Hughes CLJr, Morgan TM, Burke GL. Soybean isoflavones improve cardiovascular risk factors without affecting the reproductive system of peripubertal rhesus monkeys. J Nutr. 1996 Jan;126(1):43-50.
Anthony MS, Clarkson TB, Weddle DL, Wolfe MS. Effects of soy protein phytoestrogens on cardiovascular risk. J Nutr. 1995 Mar;125(Suppl 3):803S-4S.